Table 2.

Patient Demographics and Early Outcomes

	Pre-ERP (N=20)	Post-ERP (N=20)	P-value
Median Age at Surgery	11.4 years (7.7–25.1)	11.3 years (4.1–21.4)	0.61
Sex			0.52
Male	7 (35%)	10 (50%)
Female	13 (65%)	10 (50%)
Presence of Ventriculoperitoneal Shunt	7 (35%)	8 (40%)	0.99
Procedure *
Ileocystoplasty	13 (65%)	18 (90%)	0.13
Continent Catheterizable Channel	14 (70%)	10 (50%)	0.33
Bladder neck reconstruction, bladder neck sling, or bladder neck closure	7 (35%)	3 (15%)	0.27
Ureteral reimplant	2 (10%)	0	0.49
Malone Antegrade Continence Enema (MACE)	5 (25%)	4 (20%)	0.99
Post-operative Length of Stay (days)	9 (range 2–31)	4 (range 3–29)	<0.05
30- day Highest Clavien Grade of Complications			0.15
Clavien I	4 (20%)	10 (50%)
Clavien II	9 (45%)	6 (30%)
Clavien III	6 (30%)	3 (15%)
Clavien IV or V	0	0
30-day Readmissions	4 (20%)	6 (30%)	0.72
30-day Unplanned Return to the Operating Room	6 (30%)	3 (15%)	0.45

^*Patients may have more than one procedure